Key Event Components

  • Key Event Components (KECs) are used to describe Key Events (KEs) in a computable way, by defining an action, processes, and object term that maps to controlled vocabulary and ontology terms.
  • KECs on this page can be filtered by the action, process, and object terms, as well as by source ontologies.
  • Link to source ontology terms are provided in cases where the URL was available when the ontology terms were added to the AOP-Wiki database.
  • A complete list of all KECs is available in TSV format on the Downloads Page.
Showing 1 to 25 of 1145 KECs
Clear Table Filters
ID Action Process Object Associated Key Events (KEs)
100 decreased fertility (MESH:D005298)
68 decreased lymphocyte (CL:0000542) 168: Decreased, Lymphocytes
134 decreased eggshell (UBERON:0005079) 106: Reduction, Eggshell thickness
29 abnormal ketone body (CHEBI:73693) 862: Not Increased, Circulating Ketone Bodies
135 functional change eggshell (UBERON:0005079) 119: N/A, Gap
126 increased bile (UBERON:0001970) 214: Bile accumulation, Pathological condition
78 increased decreased heart rate (MESH:D001919) 444: Increased, Atrioventricular block and bradycardia
132 decreased prostaglandin E2 (CHEBI:15551)
95 morphological change male reproductive organ (UBERON:0003135) 348: Malformation, Male reproductive tract
121 decreased nitric oxide (CHEBI:16480) 193: Decreased, Nitric Oxide
118 disrupted mitochondrial respiratory chain (GO:0005746) 178: Mitochondrial electron transport chain, disrupted
41 decreased thyroxine (CHEBI:30660)
86 decreased glutathione (CHEBI:16856) None
129 occurrence cholestasis (MESH:D002779)
77 increased atrioventricular block (MESH:D054537) 444: Increased, Atrioventricular block and bradycardia
76 increased acetylcholine (CHEBI:15355) 10: Acetylcholine accumulation in synapses
11 occurrence Parkinsonian disorders (MESH:D020734) 896: Parkinsonian motor deficits
117 increased calcium ion (CHEBI:39124) 50: Increase, Ca++ (intracellular)
115 decreased Follicle stimulating hormone (CHEBI:81569) 129: Reduction, Gonadotropins, circulating concentrations
33 decreased 17beta-estradiol (CHEBI:16469)
6 functional change mitochondrion (GO:0005739)
114 decreased Luteinizing hormone (CHEBI:81568)
43 morphological change hippocampal formation (UBERON:0002421) None
110 decreased vitellogenins (MESH:D014819) 221: Reduction, Plasma vitellogenin concentrations
94 decreased testosterone (CHEBI:17347)